IRX THERAPEUTICS, INC.

Profile

Company Names

IRX THERAPEUTICS, INC.
IRX THERAPEUTICS INC

Addresses

654 MADISON AVENUE, SUITE 1601, NEW YORK, NY 10065

140 W 57TH ST, SUITE 3D, NEW YORK, NY 10019

140 W. 57TH ST., SUITE 9C, NEW YORK, NY 10019

140 W 57TH ST, SUITE 9C, NEW YORK, NY 10019

Phone Numbers

212-582-1199
212 582-1199

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$109,070,775.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2016-12-30 
$33,230,669.00 
$33,230,669.00 
$0.00 
Equity 
7
2016-10-18 
$6,400,000.00 
$8,000,000.00 
$1,600,000.00 
Debt 
6
2016-04-30 
$2,000,000.00 
$15,000,000.00 
$13,000,000.00 
Debt 
5
2014-12-31 
$40,585,742.00 
$40,585,742.00 
$0.00 
Equity 
4
2014-02-28 
$15,094,601.00 
$18,000,000.00 
$2,905,399.00 
Debt 
3
2012-05-15 
$1,500,000.00 
$1,500,000.00 
$0.00 
Debt 
2
2010-05-28 
$8,047,991.00 
INDEFINITE 
INDEFINITE 
Debt 
1
2009-10-15 
$2,211,772.00 
$6,000,000.00 
$3,788,228.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHARLES 
R. 
CHERINGTON 
DIRECTOR
DAVID 
H. 
DEMING 
DIRECTOR
GEORGE 
P. 
DENNY III 
DIRECTOR
JOHN 
W. 
HADDEN 
DIRECTOR
JOHN 
W. 
HADDEN II 
EXECUTIVE OFFICER, DIRECTOR
JOHN 
D. 
HALPERN 
DIRECTOR
JEFFREY 
 
HWANG 
EXECUTIVE OFFICER
JEFFREY 
 
HWUANG 
EXECUTIVE OFFICER
MARK 
W. 
LEUCHTENBERGER 
EXECUTIVE OFFICER, DIRECTOR
FERID 
 
MURAD 
DIRECTOR
CURTIS 
P. 
ROBB 
EXECUTIVE OFFICER
ZYGMUND 
 
ROTH 
EXECUTIVE OFFICER
MONIL 
 
SHAH 
EXECUTIVE OFFICER
JOHN 
T. 
SPITZNAGEL 
DIRECTOR
HOWARD 
H. 
STEVENSON 
DIRECTOR
EDMUND 
 
TRUELL 
DIRECTOR
LAWRENCE 
M. 
WOLF 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-10-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-04-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-02-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-05-15 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Debt 
2010-05-28 
D
OTHER HEALTH CARE 
 
NO REVENUES 
Equity 
2009-10-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#